BioAtla将实施50比1的股票整合

2026-04-01 04:12

BioAtla (BCAB) on Tuesday said it will carry out a 50-for-1 share consolidation of its common stock, effective April 6, 2026, as it seeks to raise its share price to meet the $1.00 minimum bid requirement for continued listing on the Nasdaq Capital Market.
The company’s shares will continue trading under the ticker “BCAB” and begin trading on a split-adjusted basis when markets open on the effective date.
Under the consolidation, every 50 shares of issued and outstanding common stock will be converted into one share.
No fractional shares will be issued, with eligible shareholders receiving cash in lieu based on the closing price on the effective date.
The move follows stockholder approval at a March 23 special meeting tied to a merger plan involving the company and its wholly owned subsidiary.
BioAtla added that equity plan share availability, as well as outstanding stock options and warrants, will be proportionately adjusted.
The consolidation will not affect the par value or authorized share count.
BCAB closed +6.16% at $0.1635.
Source: Press Release

More on BioAtla